J P Buyniski

510 total citations
20 papers, 398 citations indexed

About

J P Buyniski is a scholar working on Molecular Biology, Gastroenterology and Physiology. According to data from OpenAlex, J P Buyniski has authored 20 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Gastroenterology and 4 papers in Physiology. Recurrent topics in J P Buyniski's work include Gastroesophageal reflux and treatments (3 papers), Gastrointestinal motility and disorders (2 papers) and Pain Mechanisms and Treatments (2 papers). J P Buyniski is often cited by papers focused on Gastroesophageal reflux and treatments (3 papers), Gastrointestinal motility and disorders (2 papers) and Pain Mechanisms and Treatments (2 papers). J P Buyniski collaborates with scholars based in United States, Germany and United Kingdom. J P Buyniski's co-authors include R L Cavanagh, Jonas A. Gylys, John Fleming, M. E. Bierwagen, Anthony W. Pircio, Hugh A. Tilson, John E. Schurig, Rachael Wright, J. S. Gidda and R. R. Crenshaw and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and European Journal of Pharmacology.

In The Last Decade

J P Buyniski

19 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J P Buyniski United States 11 130 101 69 69 56 20 398
J. H. Cort Czechia 18 150 1.2× 60 0.6× 72 1.0× 63 0.9× 10 0.2× 38 677
F Groß Germany 13 100 0.8× 49 0.5× 50 0.7× 56 0.8× 9 0.2× 43 525
Seyed Hassan Tonekaboni Iran 15 194 1.5× 114 1.1× 39 0.6× 163 2.4× 8 0.1× 83 677
K. Saameli Switzerland 9 44 0.3× 46 0.5× 18 0.3× 18 0.3× 7 0.1× 19 292
R. Kelly Hester United States 13 184 1.4× 66 0.7× 20 0.3× 178 2.6× 10 0.2× 31 429
J. A. Christensen Norway 11 117 0.9× 73 0.7× 29 0.4× 36 0.5× 3 0.1× 26 408
Susan E. Libretto United Kingdom 10 47 0.4× 41 0.4× 18 0.3× 78 1.1× 9 0.2× 25 381
Bengt Nilsson Sweden 13 89 0.7× 109 1.1× 47 0.7× 68 1.0× 5 0.1× 23 483
Zhiling Xiong United States 13 265 2.0× 153 1.5× 109 1.6× 109 1.6× 10 0.2× 24 476
Shuichi Nosaka Japan 14 109 0.8× 58 0.6× 113 1.6× 123 1.8× 5 0.1× 52 484

Countries citing papers authored by J P Buyniski

Since Specialization
Citations

This map shows the geographic impact of J P Buyniski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Buyniski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Buyniski more than expected).

Fields of papers citing papers by J P Buyniski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J P Buyniski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Buyniski. The network helps show where J P Buyniski may publish in the future.

Co-authorship network of co-authors of J P Buyniski

This figure shows the co-authorship network connecting the top 25 collaborators of J P Buyniski. A scholar is included among the top collaborators of J P Buyniski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Buyniski. J P Buyniski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poindexter, Graham S., Michael A. Foley, James E. Macdonald, et al.. (1993). Isosteric replacement in a series of β-substituted monophosphonate calcium antagonists. Bioorganic & Medicinal Chemistry Letters. 3(12). 2817–2820. 1 indexed citations
2.
Cavanagh, R L & J P Buyniski. (1989). Effect of BMY‐25368, a potent and long‐acting histamine H2‐receptor antagonist, on gastric secretion and aspirin‐induced gastric lesions in the dog. Alimentary Pharmacology & Therapeutics. 3(3). 299–313. 10 indexed citations
3.
Monković, Ivo, et al.. (1989). Potential non-dopaminergic gastrointestinal prokinetic agents in the series of substituted benzamides. European Journal of Medicinal Chemistry. 24(3). 233–239. 9 indexed citations
4.
Gylys, Jonas A., et al.. (1988). BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 830–837. 35 indexed citations
5.
Cavanagh, R L, J P Buyniski, & Samuel Schwartz. (1987). Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.. Journal of Pharmacology and Experimental Therapeutics. 243(3). 1179–1184. 6 indexed citations
6.
Wright, Rachael, et al.. (1987). Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis. Inflammation Research. 21(3-4). 241–243. 23 indexed citations
7.
Gidda, J. S. & J P Buyniski. (1986). Swallow-evoked peristalsis in opossum esophagus: role of cholinergic mechanisms. American Journal of Physiology-Gastrointestinal and Liver Physiology. 251(6). G779–G785. 19 indexed citations
8.
Cavanagh, R L, et al.. (1983). A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.. Journal of Pharmacology and Experimental Therapeutics. 224(1). 171–179. 35 indexed citations
9.
Fleming, John & J P Buyniski. (1983). Anagrelide. Cardiovascular Drug Reviews. 1(1). 277–294. 3 indexed citations
10.
Fleming, John, et al.. (1981). The Interaction Of Platelet Active Drugs With Prostacyclin In Vitro And Against Biolaser Induced Intravascular Thrombosis. Thrombosis and Haemostasis. 1 indexed citations
11.
Roebel, Lawrence E., R L Cavanagh, & J P Buyniski. (1979). Comparative gastrointestinal and biliary tract effects of morphine and butorphanol (Stadol).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 10(4). 225–38. 11 indexed citations
12.
Fleming, John & J P Buyniski. (1979). A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A). Thrombosis Research. 15(3-4). 373–388. 41 indexed citations
13.
Schurig, John E., R L Cavanagh, & J P Buyniski. (1978). Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.. PubMed. 233(2). 296–304. 33 indexed citations
14.
Fleming, John & J P Buyniski. (1977). Enhanced platelet aggregability in dogs following myocardial infarction. Life Sciences. 20(5). 843–848. 4 indexed citations
15.
Tilson, Hugh A., et al.. (1977). Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats. European Journal of Pharmacology. 43(2). 99–105. 51 indexed citations
16.
Fleming, John, et al.. (1976). The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs. European Journal of Pharmacology. 40(1). 57–62. 3 indexed citations
17.
Pircio, Anthony W., Jonas A. Gylys, R L Cavanagh, J P Buyniski, & M. E. Bierwagen. (1976). The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.. PubMed. 220(2). 231–57. 97 indexed citations
18.
Fleming, John, J P Buyniski, R L Cavanagh, & M. E. Bierwagen. (1975). Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate.. Journal of Pharmacology and Experimental Therapeutics. 194(2). 435–449. 14 indexed citations
19.
Cavanagh, R L, et al.. (1974). Possible mechanism for the fibrinolytic effect of certain bis-tetrahydroisoquinolines: Evidence for histamine release. Thrombosis Research. 5(5). 633–645. 1 indexed citations
20.
Buyniski, J P, et al.. (1971). Effect of Gram-Negative Endotoxin on Cerebral Circulation. European Neurology. 6(1-6). 253–258. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. H. Cort Breakdown of academic impact, for papers by F Groß Breakdown of academic impact, for papers by Seyed Hassan Tonekaboni Breakdown of academic impact, for papers by K. Saameli Breakdown of academic impact, for papers by R. Kelly Hester Breakdown of academic impact, for papers by J. A. Christensen Breakdown of academic impact, for papers by Susan E. Libretto Breakdown of academic impact, for papers by Bengt Nilsson Breakdown of academic impact, for papers by Zhiling Xiong Breakdown of academic impact, for papers by Shuichi Nosaka
Rankless by CCL
2026